Treatment

• 

  From the Editor-in-Chief

  Cancer and the Microbiome

  Altering the gut microbiota and microbiome could become a strategy for cancer prevention and treatment.

  by William G. Nelson, MD, PhD

• 

  Forward Look

  What Is CRISPR?

  Q&A with oncologist Howard Kaufman on the new gene-editing tool.

  by Chris Palmer

• 

  Forward Look

  Little Consensus on Ovarian Cancer Monitoring

  Tests and scans may be overused.

  by Kate Yandell

• 

  Making a Match

  Oncologists and researchers are looking for new drug combinations that extend patient survival without worsening side effects, but it's a daunting task.

  by Stephen Ornes

• 

  Forward Look

  Thyroid Tumor Gets New Name

  Panel reclassifies a type of thyroid tumor, says it's not cancer.

  by Yasmine Iqbal

• 

  Forward Look

  Many Cancers in HIV-Positive Patients Go Untreated

  Study suggests need to educate patients with HIV and their doctors.

  by Kate Yandell

• 

  Editor's Letter

  Cancer and Watchful Waiting

  Watching and waiting for cancer to progress can be an alternative to active treatment.

  by Kevin McLaughlin

• 

  Forward Look

  Getting to the Root of Brain Cancer

  Q&A with neurosurgeon Peter Dirks on stem cells and brain cancer.

  by Chris Palmer

• 

  Forward Look

  A Report Card on Active Surveillance

  Many men with untreated prostate cancer are not getting proper follow-up.

  by Heather Stringer

• 

  Forward Look

  Radiation Appointments Are Numerous, And Necessary

  New study shows impact of missed treatments.

  by Marilyn Fenichel